Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
AMNEAL PHARMACEUTICALS, INC. (AMRX) had Weighted-Average Shares Outstanding (Diluted) of 328.09M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$814.32M |
|
$35.08M |
|
$517.13M |
|
$297.19M |
|
$702.29M |
|
$112.03M |
|
$-56.80M |
|
$55.23M |
|
$55.23M |
|
$49.57M |
|
$49.57M |
|
$49.57M |
|
$49.57M |
|
$112.03M |
|
-- |
|
314.46M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
328.09M |
$0.11 |
|
$0.11 |
|
| Balance Sheet Financials | |
$1.91B |
|
$442.95M |
|
$1.77B |
|
$3.68B |
|
$881.63M |
|
$2.57B |
|
$2.87B |
|
$3.75B |
|
-- |
|
$-1.23B |
|
$-71.33M |
|
-- |
|
| Cash Flow Statement Financials | |
$339.99M |
|
$-112.26M |
|
$-31.53M |
|
$118.42M |
|
$312.94M |
|
$194.52M |
|
$31.95M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|